Hot Pursuit     20-Sep-23
Caplin Point's subsidiary gets US FDA approval for blood pressure restoration drug
Caplin Point Laboratories informed that Caplin Steriles has been granted final approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Norepinephrine Bitartrate injection.

The said injection is a generic therapeutic equivalent version of (RLD), LEVOPHED injection of Hospira Inc.

Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients with acute hypotensive states.

According to IQVIATM (IMS Health), Norepinephrine Bitartrate injection USP had US sales of approximately $40 million for the 12-month period ending June 2023.

Caplin Steriles, a subsidiary of Caplin Point Laboratories, is a niche sterile product manufacturing company that is approved by several regulatory agencies such as US FDA, EU-GMP and ANVISA. Caplin Steriles has developed and filed 31 ANDAs in USA on its own and with partners, with 24 approvals so far. The company is also working on a portfolio of 40+ simple and complex injectable and ophthalmic products that it intends to file over the next 4 years.

Caplin Point Laboratories is engaged in the business of pharmaceuticals - producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.

The company's consolidated net profit jumped 29.2% to Rs 102.11 crore in Q4 FY23 as compared with Rs 79.06 crore in Q4 FY22. Net sales rose 14.8% year on year to Rs 389.28 crore in Q4 FY23 over Q4 FY22.

The scrip shed 0.70% to currently trade at Rs 1034.40 on the BSE.

Previous News
  Caplin Point Laboratories consolidated net profit rises 19.86% in the June 2024 quarter
 ( Results - Announcements 07-Aug-24   15:14 )
  Board of Caplin Point Laboratories recommends final dividend
 ( Corporate News - 07-Aug-24   16:31 )
  Caplin Point arm commences operations at Oncology facility in Chennai
 ( Hot Pursuit - 27-Mar-24   13:47 )
  Caplin Steriles receives USFDA approval for Ofloxacin Ophthalmic Solution USP 0.3%
 ( Corporate News - 16-Apr-24   11:32 )
  Caplin Point Laboratories to convene AGM
 ( Corporate News - 07-Aug-24   16:31 )
  Caplin Point Laboratories allots 1,400 equity shares under ESOP
 ( Corporate News - 16-Jul-24   19:21 )
  Sanofi India Ltd leads losers in 'A' group
 ( Hot Pursuit - 13-Jun-24   15:00 )
  Caplin Point Laboratories fixes record date for interim dividend
 ( Market Beat - Reports 06-May-21   16:17 )
  Caplin Steriles receives USFDA approval for Labetalol Hydrochloride Injection
 ( Corporate News - 08-Sep-21   12:59 )
  Caplin Point Laboratories announces resignation of company secretary
 ( Corporate News - 27-Jun-22   10:45 )
  Caplin Point Laboratories consolidated net profit rises 10.08% in the December 2020 quarter
 ( Results - Announcements 04-Feb-21   13:41 )
Other Stories
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
  Power Grid Corporation of India Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top